Qsymia and lifestyle management therapy for pediatric obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Apr 2023: Trial registered, NCT05834062
  2. 26 Oct 2023: Trial withdrawn, NCT05834062

The trials

NCT05834062: Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
17 Oct 2023
Primary completion
Aug 2026
Arms
Medication arm
Results
None posted
  1. 28 Apr 2023: Trial registered
  2. 26 Oct 2023: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.